0001144204-16-115995.txt : 20160802
0001144204-16-115995.hdr.sgml : 20160802
20160802165634
ACCESSION NUMBER: 0001144204-16-115995
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160731
FILED AS OF DATE: 20160802
DATE AS OF CHANGE: 20160802
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DERMA SCIENCES, INC.
CENTRAL INDEX KEY: 0000892160
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 232328753
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6095144744
MAIL ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DERMA SCIENCES INC
DATE OF NAME CHANGE: 19940513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wolfenson Barry
CENTRAL INDEX KEY: 0001354818
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13070
FILM NUMBER: 161801213
MAIL ADDRESS:
STREET 1: DERMA SCIENCES, INC.
STREET 2: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
v445796_form4.xml
FORM 4
X0306
4
2016-07-31
1
0000892160
DERMA SCIENCES, INC.
DSCI
0001354818
Wolfenson Barry
DERMA SCIENCES, INC.
214 CARNEGIE CENTER, SUITE 300
PRINCETON
NJ
08540
0
0
0
1
See Remarks
Stock Option (right to buy)
13.39
2014-02-14
4
A
0
5875
0
A
2014-02-14
2024-02-14
Common Stock
5875
0
D
Stock Option (right to buy)
8.83
2015-02-12
4
A
0
6500
0
A
2015-02-12
2025-02-12
Common Stock
6500
0
D
Stock Option (right to buy)
3.30
2016-03-02
4
A
0
12000
0
A
2016-03-02
2026-03-02
Common Stock
12000
0
D
The options, granted pursuant to the issuer's equity incentive plan and which vested as to 25% on the grant date and as to an additional 25% for each of the following three years, vested on an accelerated basis. Any remaining equity awards previously reported that did not vest prior to July 31, 2016 were forfeited effective as of such date.
The options were originally granted in consideration of the reporting person's past services to the issuer and without payment of cash consideration.
Former Group President, Advanced Wound Care
/s/ Barry J. Wolfenson
2016-08-02